Evaluation of a Suprachoroidal Retinal Prosthesis: A 44 Channel Fully Implantable Study
Summary
This study is a proof of principal, to evaluate a safety and efficacy of a prototype suprachoroidal retinal implant. The study involves the use of 44Ch Bionic Eye Device and will assess clinical outcomes in participants with Retinitis Pigmentosa. This research aims to generate evidence that could support future development and regulatory approval of innovative neurotechnology-based treatments for affected patients.
Why it matters
This trial represents an important advancement in neurotechnology for treating Retinitis Pigmentosa. If successful, the device-based intervention could provide a new therapeutic option for patients who have not responded adequately to conventional treatments or therapies. The study results may inform future regulatory approval pathways and establish clinical precedent that could benefit broader patient populations with similar conditions.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trial